TrialDrugs in R&D2010

Safety, tolerability, and pharmacokinetics of etamicastat, a novel dopamine-β-hydroxylase inhibitor, in a rising multiple-dose study in young healthy subjects.

Teresa Nunes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.